2015
DOI: 10.1007/s00059-015-4332-1
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Due to the increased life expectancy and continual improvements in cardiological treatment options, diseases of the tricuspid valve, in particular tricuspid valve insufficiency will become increasingly more recognized as an interventional target. While tricuspid stenosis is rare and can be effectively treated with balloon valvuloplasty, no effective transcatheter approach to tricuspid regurgitation (TR) has yet been established. As the tricuspid annulus is a complex and highly dynamic structure that offers lit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…Other devices used include the Mitralign (Mitralign), a device originally designed to remodel the mitral annulus using pledgeted sutures, which has been successfully placed in some patients with severe tricuspid regurgitation [ 85 ]. The TriCinch (4Tech) [ 86 ], a percutaneous device designed for annular cinching of the tricuspid annulus, and the Millipede (Millipede), which involves the transcutaneous placement of a tricuspid annular ring with an attachment system, are still in pre-clinical trials.…”
Section: Catheter-based Therapiesmentioning
confidence: 99%
“…Other devices used include the Mitralign (Mitralign), a device originally designed to remodel the mitral annulus using pledgeted sutures, which has been successfully placed in some patients with severe tricuspid regurgitation [ 85 ]. The TriCinch (4Tech) [ 86 ], a percutaneous device designed for annular cinching of the tricuspid annulus, and the Millipede (Millipede), which involves the transcutaneous placement of a tricuspid annular ring with an attachment system, are still in pre-clinical trials.…”
Section: Catheter-based Therapiesmentioning
confidence: 99%